↓ Skip to main content

Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective

Overview of attention for article published in Frontiers in immunology, September 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
5 X users
patent
4 patents

Citations

dimensions_citation
79 Dimensions

Readers on

mendeley
181 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective
Published in
Frontiers in immunology, September 2014
DOI 10.3389/fimmu.2014.00439
Pubmed ID
Authors

Cristina Eguizabal, Olatz Zenarruzabeitia, Jorge Monge, Silvia Santos, Miguel Angel Vesga, Natalia Maruri, Arantza Arrieta, Marta Riñón, Estibaliz Tamayo-Orbegozo, Laura Amo, Susana Larrucea, Francisco Borrego

Abstract

Natural killer (NK) cells play an essential role in the fight against tumor development. Over the last years, the progress made in the NK-cell biology field and in deciphering how NK-cell function is regulated, is driving efforts to utilize NK-cell-based immunotherapy as a promising approach for the treatment of malignant diseases. Therapies involving NK cells may be accomplished by activating and expanding endogenous NK cells by means of cytokine treatment or by transferring exogenous cells by adoptive cell therapy and/or by hematopoietic stem cell transplantation. NK cells that are suitable for adoptive cell therapy can be derived from different sources, including ex vivo expansion of autologous NK cells, unstimulated or expanded allogeneic NK cells from peripheral blood, derived from CD34+ hematopoietic progenitors from peripheral blood and umbilical cord blood, and NK-cell lines. Besides, genetically modified NK cells expressing chimeric antigen receptors or cytokines genes may also have a relevant future as therapeutic tools. Recently, it has been described the derivation of large numbers of functional and mature NK cells from pluripotent stem cells, both embryonic stem cells and induced pluripotent stem cells, which adds another tool to the expanding NK-cell-based cancer immunotherapy arsenal.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 181 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 178 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 35 19%
Student > Ph. D. Student 35 19%
Student > Bachelor 23 13%
Student > Master 22 12%
Other 11 6%
Other 20 11%
Unknown 35 19%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 41 23%
Agricultural and Biological Sciences 41 23%
Medicine and Dentistry 29 16%
Immunology and Microbiology 14 8%
Engineering 8 4%
Other 13 7%
Unknown 35 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2023.
All research outputs
#3,806,772
of 25,416,581 outputs
Outputs from Frontiers in immunology
#4,312
of 31,621 outputs
Outputs of similar age
#39,967
of 258,644 outputs
Outputs of similar age from Frontiers in immunology
#22
of 162 outputs
Altmetric has tracked 25,416,581 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,621 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 258,644 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 162 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.